Purpose
to make monoclonal antibodies more accessible to patients worldwide, particularly those in developing countries, by reducing costs and increasing the scale of manufacturing
Grantee
Division
Global Health
Date
OCTOBER 2021
Region served
GLOBAL
Committed amount
$1,269,000
Grant topic
Vaccine Development
Duration (months)
19
Grantee location
Bedford, Massachusetts, United States
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.